Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation.
Nakamura Y, Urakami T, Ishimaru K, Vuong Tran NQ, Shimizu T, Sinko W, Takahashi T, Marappan S, Narayanan K, Poddutoori R, Terada Y, Nakao A. Nakamura Y, et al. Among authors: terada y. J Allergy Clin Immunol Glob. 2024 Apr 3;3(3):100249. doi: 10.1016/j.jacig.2024.100249. eCollection 2024 Aug. J Allergy Clin Immunol Glob. 2024. PMID: 38764489 Free PMC article.
Cathepsin C inhibition reduces neutrophil serine protease activity and improves activated neutrophil-mediated disorders.
Nishibata Y, Arai S, Taniguchi M, Nakade I, Ogawa H, Kitano S, Hosoi Y, Shindo A, Nishiyama R, Masuda S, Nakazawa D, Tomaru U, Shimizu T, Sinko W, Nagakura T, Terada Y, Ishizu A. Nishibata Y, et al. Among authors: terada y. Nat Commun. 2024 Aug 22;15(1):6519. doi: 10.1038/s41467-024-50747-6. Nat Commun. 2024. PMID: 39174512 Free PMC article.
Targeting macrophage circadian rhythms with microcurrent stimulation to activate cancer immunity through phagocytic defense.
Yoshida Y, Tanihara T, Hamasaki K, Tsurusaki F, Fukuda T, Adachi S, Terada Y, Otsuki K, Nishikawa N, Fukuoka K, Tsukamoto R, Hamamura K, Oyama K, Tsuruta A, Mayanagi K, Koyanagi S, Ohdo S, Matsunaga N. Yoshida Y, et al. Among authors: terada y. Theranostics. 2025 Jan 1;15(2):340-361. doi: 10.7150/thno.100748. eCollection 2025. Theranostics. 2025. PMID: 39744689 Free PMC article.
Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease.
Yoshimura K, Shima A, Kambe D, Furukawa K, Nishida A, Wada I, Sakato Y, Sakamaki-Tsukita H, Terada Y, Yamakado H, Taruno Y, Nakanishi E, Sawamura M, Fujimoto K, Fushimi Y, Okada T, Nakamoto Y, Hanakawa T, Takahashi R, Sawamoto N. Yoshimura K, et al. Among authors: terada y. Eur J Neurol. 2025 Jan;32(1):e70022. doi: 10.1111/ene.70022. Eur J Neurol. 2025. PMID: 39716907 Free PMC article.
Monocyte/Macrophage-Specific Loss of ARNTL Suppresses Chronic Kidney Disease-Associated Cardiac Impairment.
Yoshida Y, Nishikawa N, Fukuoka K, Tsuruta A, Otsuki K, Fukuda T, Terada Y, Tanihara T, Kumamoto T, Tsukamoto R, Nishi T, Oyama K, Hamamura K, Mayanagi K, Koyanagi S, Ohdo S, Matsunaga N. Yoshida Y, et al. Among authors: terada y. Int J Mol Sci. 2024 Dec 3;25(23):13009. doi: 10.3390/ijms252313009. Int J Mol Sci. 2024. PMID: 39684718 Free PMC article.
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).
Shoji T, Takatori E, Nagasawa T, Kagabu M, Baba T, Shigeto T, Matsumura Y, Shimizu D, Terada Y, Seino M, Ohta T, Nagase S, Shigeta S, Tokunaga H, Shimada M, Kaiho-Sakuma M, Furukawa S, Soeda S, Watanabe T, Takahashi F, Yokoyama Y. Shoji T, et al. Among authors: terada y. Cancers (Basel). 2024 Nov 12;16(22):3801. doi: 10.3390/cancers16223801. Cancers (Basel). 2024. PMID: 39594756 Free PMC article.
1,457 results